2014 ACR/ARHP Annual Meeting

November 14-19, 2014. Boston, MA.

View by Title View Sessions

Jump to: View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z

Abstract Number: 1672

Facilitating the Medication Decision-Making process—What Do Patients with Lupus Nephritis Say?
Abstract Number: 590

Factors Associated with a Poor Functional Prognosis in Early Inflammatory Back Pain: Results from the DESIR Cohort
Abstract Number: 272

Factors Associated with Choice of First Biologic Among Children with Juvenile Idiopathic Arthritis: A Combined Analysis from 2 UK Paediatric Biologic Registers
Abstract Number: 2633

Factors Associated with Damage Accrual and Survival in Chinese Patients with Systemic Lupus Erythematosus (SLE): A Prospective Cohort Analysis of 747 Patients
Abstract Number: 1056

Factors Associated with Impairment on Quality of Life in Early or Established RA Patients
Abstract Number: 2384

Factors Associated with Methotrexate Treatment Duration, Including Subcutaneous Use, in Patients with Rheumatoid Arthritis: Observations from the VA Database
Abstract Number: 1331

Factors Associated with Pain in Children with Hypermobility – a Pilot Study
Abstract Number: 1066

Factors Associated with Recording of Rheumatoid Arthritis on Death Certificate
Abstract Number: 2025

Factors Associated with Time to Diagnosis from Symptom Onset in Early Rheumatoid Arthritis Patients
Abstract Number: 2440

Factors Influencing Health Related Quality of Life (HR-QOL) for Korean Patients with Rheumatoid Arthritis
Abstract Number: 231

Factors Predicting Fracture in the over-75s: An Observational Case-Control Study
Abstract Number: 1776

Factors Predictive of ANCA-Associated Vasculitis Relapse in Patients Given Rituximab-Maintenance Therapy
Abstract Number: 788

Fast-Track Diagnostic Procedure for Giant Cell Arteritis
Abstract Number: 2986

Fat Metaplasia on MRI of the Sacroiliac Joints Is a Lead Indicator of Radiographic Progression in the Spine of Patients with Ankylosing Spondylitis
Abstract Number: 2372

Fatigue and Related Factors in Patients with Rheumatoid Arthritis Treated with Tocilizumab in Daily Clinical Setting
Abstract Number: 377

Fatigue Fluctuates Substantially over Time in Rheumatoid Arthritis Patients Despite Stable Disease Activity during Treatment with Biological Agents
Abstract Number: 2607

Fatigue in Ankylosing Spondylitis: A Multivariable Analysis Implicates Inflammation As the Key Determinant of Disability
Abstract Number: 2704

Fatigue in Systemic Sclerosis
Abstract Number: 2049

Fatigue Is a Risk Factor for Subsequent Functional Decline in SLE
Abstract Number: 672

Favorable Response to Belimumab in Pediatric-Onset Systemic Lupus Erythematosus
Abstract Number: 989

Fcgamma Receptor IIb Facilitates Rapid Internalisation of Rituximab (type 1 anti-CD20 antibody) in B Cells from Patients with RA and SLE and Contributes to Less Efficient B Cell Lysis Than Type 2 Anti-CD20 Antibodies, in Vitro
Abstract Number: 1129

FCGR2A Polymorphism and Response to Anti-TNF Treatment in Rheumatoid Arthritis
Abstract Number: 2730

FcγRIIIa Ligation in Human Peripheral CD4⁺ T-Cells Generate T_H17 like Population
Abstract Number: 1176

Feasibility and Clinical Implication of Radiocarpal Cartilage T_1ρ MR Imaging in Rheumatoid Arthritis
Abstract Number: 1185

Feature of Fatty Deposition in Sacroiliac Joints in Ankylosing Spondylitis Patients Seen By MRI
Abstract Number: 2190

Features of Interstitial Lung Disease Associated with Connective Tissue Disease in a Spanish Southwest Cohort
Abstract Number: 1312

Features, Treatment and Outcome of Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus
Abstract Number: 1197

Febuxostat Inhibits Monosodium Urate Crystal-Induced IL-1beta Secretion and Cell Death Via ROS- and Intracellular ATP-Dependent Pathways
Abstract Number: 578

Female Patients but Not Male Patients with Ankylosing Spondylitis Are at Increased Risk of Developing Ischemic Heart Disease: A Population-Based Cohort Study
Abstract Number: 1093

Female Sexual Function in Fibromyalgia
Abstract Number: 2736

Female Specific Increase in T Cell Glycosylation in Lupus
Abstract Number: 1011

Fibroblast Growth Factor-2 and Its Receptor Antagonists in Osteoarthritis
Abstract Number: 1022

Fibroblast-like Synovial Cells and Monocytes Team up in the Organization and the Dynamic Modelling of the Synovial Tissue
Abstract Number: 1001

Fibroblast-like Synoviocytes Inhibit Wnt Signaling Pathway By Secreting Dockcop-1
Abstract Number: 1384

Fibromyalgia and Its Effect on Treatment Response in Early Rheumatoid Arthritis Patients
Abstract Number: 1117

Fibromyalgia Patients Taking Opioids Have Low Self-Efficacy and High Pain Catastrophizing but No Reduction in Pain or Improvement in Activity
Abstract Number: 1096

Fibromyalgia Patients Who Have More Symptoms at Their Initial Office Visit Tend to Have a Worse Clinical Course
Abstract Number: 2056

Fibromyalgia Symptoms Beyond the Pain and Its Impact on the Patient
Abstract Number: 1982

Final Year Medical Students Prefer E-Reading Content to Interactive Case-Based Quizzes in a Pediatric Rheumatology E-Learning Module
Abstract Number: 918

Findings from Denosumab (Prolia^®) Postmarketing Safety Surveillance for Serious Infections
Abstract Number: 2015

Fine Particulate Air Pollution and Systemic Autoimmune Rheumatic Disease in Two Canadian Provinces
Abstract Number: 625

Fine-Mapping Major Histocompatibility Complex Associations Identified Contribution of Multiple Class I and II HLA Genes on Risk of Psoriasis and Its Clinical Subtypes
Abstract Number: 2918

Fine-Mapping Major Histocompatibility Complex Associations in ACPA-Positive Rheumatoid Arthritis Identified Shared HLA Amino Acid Polymorphisms in Asian and European Populations
Abstract Number: 511

First and Second Line Continuation Rates of Non Anti-TNF-α Biological DMARD for the Treatment of Rheumatoid Arthritis
Abstract Number: 457

First Confirmation Data of Long Term Safety for Tocilizumab in Real-World Setting; 3 Year Follow-up Postmarketing Surveillance of 5573 Patients with Rheumatoid Arthritis in Japan
Abstract Number: 2022

First Nations Persons Have an Increased Risk of Developing Rheumatoid Arthritis with an Early Onset Age but Are Seen Less Frequently By Rheumatologists: A Population Based Study
Abstract Number: 1837

First Results of a European Registries Collaborative Project to Compare the Spectrum of Lymphomas Between Different Exposure Groups in Rheumatoid Arthritis
Abstract Number: 905

First Step in the Development of an Ultrasound Joint Inflammation Score for Rheumatoid Arthritis: A Data Driven Approach
Abstract Number: 2667

First-Trimester Disease Activity Does Not Predict Pre-Eclampsia in SLE Pregnancy
Abstract Number: 2017

Fish Consumption and Risk of Rheumatoid Arthritis Among Women in Large Prospective Cohorts
Abstract Number: 1405

Five-Year Changes in Myocardial Structure and Function in Patients with Rheumatoid Arthritis
Abstract Number: 584

Flare in Spondyloarthritis: Proposal of a Meaningful Change in Symptomatic Outcome Measures in Axial Spondyloarthritis
Abstract Number: 292

Flares in Children with JIA: Results from the Reacch-out Cohort
Abstract Number: 2908

Flip Deficiency in Dendritic Cells Promotes Spontaneous Arthritis Mediated By Reduced Treg and Increased Autoreactive CD4⁺t Cells
Abstract Number: 279

Focus on Patient Reported Outcomes in Juvenile Idiopathic Arthritis: There Is Room to Improve Care
Abstract Number: 1465

Follicular Helper T Cells Control Autoimmunity through IL-21/IL-21 Receptor Interaction in RA Patients
Abstract Number: 1790

Follow up of an Unselected IgA Vasculitis (Henoch-Schönlein Purpura) Population at Single Rheumatology Center
Abstract Number: 1523

Follow-up Data on the Rheumatoid Arthritis Comparison of Active Therapies Trial: Observational Cohort
Abstract Number: 2286

Food Allergy and Celiac Disease in Children with Juvenile Idiopathic Arthritis
Abstract Number: 1873

Food Sources of Protein and Risk of Incident Gout in the Singapore Chinese Health Study
Abstract Number: 2052

Foot and Ankle Characteristics Associated with Falls in Adults with Rheumatoid Arthritis
Abstract Number: 213

Foot Center of Pressure in Knee Osteoarthritis (OA) and Its Association with Knee Load Reduction with Barefoot Walking
Abstract Number: 2945

Foot Structure and Function Show Associations with Lower Extremity Physical Function
Abstract Number: 1456

Foxp3+ Regulatory T Cells in Peripheral Blood and Synovial Fluid of Patients with RA: A Comparative Phenotypic Analysis
Abstract Number: 798

Frequency and Predictive Variables of Relapses in Patients with Biopsy-Proven Giant Cell Arteritis
Abstract Number: 73

Frequency and Risk Factors for Recurrent Falls in Community-Dwelling Elderly: A Population-Based Prospective Cohort Study in Brazil. the São Paulo Ageing & Health (SPAH) Study
Abstract Number: 2152

Frequency of Postoperative Deep Infection in Patients with Rheumatoid Arthritis
Abstract Number: 2408

Frequency of Rheumatoid Arthritis Flares in Clinical Practice: Analysis of a Monocentric Cohort of Patients in Stable Remission or Low Disease Activity
Abstract Number: 844

Frequency of Significant Infection in Patients with RA Following Initiation of Rituximab with up to 5 Years of Follow-up in a US Observational Study
Abstract Number: 2403

From Early Arthritis Clinic to Remission Clinic: Short-Term Outcome and Ultrasonographic-Synovitis Dynamics in Rheumatoid Arthritis Patients in DMARD-Induced SDAI-Remission during Drug-Free Follow-up
Abstract Number: 1332

From Social Support to Information Sharing, How Are Persons with Rheumatoid Arthritis Using Disease-Specific Facebook Communities? a Content Analysis
Abstract Number: 1614

Functional Analysis of Interferon Responsiveness in PBMC from SLE Donors Identifies Subgroups with Higher and Lower Disease Activity
Abstract Number: 773

Functional Autoantibodies from Patients with Systemic Sclerosis Reactive to Angiotensin II Type 1and Endothelin-1 Type a Receptor Induce Inflammatory Lymphocyte Infiltration into Lungs of Mice
Abstract Number: 610

Functional Implications of the Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) Association with Ankylosing Spondylitis and Crohn’s Disease: Impact on the Unfolded Protein Response
Abstract Number: 26

Functional Osteoclasts Differentiate Spontaneously from the Rheumatoid Joint
Abstract Number: 1458

Functional Phenotype of Synovial Monocytes Modulating Inflammatory T-Cell Response in Rheumatoid Arthritis
Abstract Number: 1616

Functional Profiling of PBMC from SLE Patients Versus Healthy Controls Identifies Subgroups with Disease-Associated Dysfunctional Signaling

Jump to: View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].